Completed
Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy
NCT03643965
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- University of Alabama at Birmingham, 1720 2nd Ave South Birmingham, Alabama, United States
- Univ of Arizona, 1501 N Campbell Ave Tucson, Arizona, United States
- Stanford University Medical Center, 777 Welch Rd Palo Alto, California, United States
- Los Angeles Biomedical Research Institute at HUMC, 1124 W. Carson Street Torrance, California, United States